...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith new VP

Still no Zenith news release and the Toft Group page on the Zenith/van der Horst search has now been removed from the Toft Group website. Hmmmmm. Change of plans? Waiting to announce?

Share
New Message
Please login to post a reply